Novo Nordisk A/S ADR buy Luise1
Start price
16.08.16
/
50%
€42.47
Target price
16.02.17
€53.67
Performance (%)
-24.82%
End price
16.02.17
€31.93
Summary
This prediction ended on 16.02.17 with a price of €31.93. The price of Novo Nordisk A/S ADR has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -24.82%. Luise1 has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Novo Nordisk A/S ADR | 6.569% | 6.569% | -47.733% | -64.960% |
| iShares Core DAX® | 0.224% | 2.031% | 21.399% | 71.886% |
| iShares Nasdaq 100 | 0.371% | -0.955% | 5.637% | 113.046% |
| iShares Nikkei 225® | 0.972% | -0.953% | 13.432% | 47.267% |
| iShares S&P 500 | 0.417% | -0.622% | 3.310% | 68.687% |
Comments by Luise1 for this prediction
In the thread Novo Nordisk A/S ADR diskutieren
Luise1 stimmt der Buy-Einschätzung von Quitte zu
Luise1 stimmt am 16.08.2016 der Buy-Einschätzung von Quitte mit dem Kursziel 49,5$ zu.
Überschrift: übertrieben
(Laufzeit überschritten)
Stopped prediction by Luise1 for Novo Nordisk A/S ADR
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€46.68
07.12.17
07.12.17
€54.12
07.06.18
07.06.18
-10.01%
07.06.18
07.06.18
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€43.45
10.02.16
10.02.16
€47.81
01.03.16
01.03.16
10.19%
01.03.16
01.03.16
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€52.96
13.07.15
13.07.15
€57.50
13.01.16
13.01.16
-2.50%
13.01.16
13.01.16

